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according to dose-volume histogram analysis in terms of PTV homogeneity and conformity indices (HI and CI) as well as OARs
dose, volume parameters.
Results. HI and CI of PTV showed no difference between 3DCRT and IMRT, IH: 11.6/12.5, IC: 0.95/0.96 respectively. V95 gave 97.8%
coverage for 3DCRT versus 99% for IMRT, V107 volumes were recorded as 11%, and 1.3% respectively for 3DCRT, IMRT. PTV showed
volume receiving isodose V107 is most important in 3DCRT than in IMRT. Tangential beam IMRT increased volume of ipsilateral
lung V5 average of 90% and reduced by 25% with 3DCRT. Ipsilateral V20 lung volume was 13%, 19% with IMRT and 3DCRT
respectively. Patients treated with IMRT, heart volume encompassed by 60% isodose line (30Gy) was reduced by an average of
42% (4% versus 7% with 3DCRT), mean heart dose by an average of 35% (495Gy versus 1400Gy with 3DCRT). Minimal heart dose
average 356Gy, in IMRT versus 90Gy in 3DCRT.
Conclusion. IMRT reduced irradiated volumes of heart and ipsilateral lung in high-dose areas but increased irradiated volumes in
low-dose areas in patients treated on left side.
http://dx.doi.org/10.1016/j.rpor.2013.03.087
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Introduction. The most common adjuvant radiotherapy strategy after breast conserving surgery consists of irradiation of the
whole breast followed by irradiation of the tumour bed. Overall treatment duration can be shortened, compared to conventional
radiation scheme, by integrating the boost irradiation in daily whole breast treatment.
Purpose. To compare dosimetry parameters of sequential versus integrated boost in breast adjuvant radiotherapy with 3D con-
ventional radiotherapy.
Material and methods. Retrospective dosimetry comparison of treatments delivered in 2011 in our department. Standard treatment
was delivered in 23–25 fractions (2.13–2Gy/fraction) to a total dose of 48.99–50Gy to whole breast, followed by boost irradiation
of 10, 16 or 20Gy depending on histopathological risk factors. SIB was delivered with doses of 2.30, 2.47 or 2.58Gy/fraction to
the tumour bed at the same time as the irradiation of the whole breast at 2.13 or 2Gy/fraction. Dose equivalence was calculated
according to the Linear Quadratic Model considering an alpha/beta of 4.6Gy. We compared dosimetry of both treatments taking
into account V95PTV, D2%PTV, V95PTVboost, D2%PTVboost, D2%whole body, V20Lung and Median Dose to the heart (in left
breasts) Statistic analysis performing T student with SPPS programme V10.
Results. 63 women were treated in our department in 2011 with adjuvant radiotherapy to whole breast + sequential boost, while
57 women were treated in the same period with SIB. Mean difference (MD) for PTV95=0.20 (95%CI: −1.25, 1.67); MD PTVD2%=0.69
(95%CI:−0.13, 1.51):MDPTVboost95=0.86 (95%CI:−0.77, 2.49);MDPTVD2%=−0.001 (95%CI:−0.53, 0.52);MDD2%whole body=1.55
(95%CI: −0.29, 3.41); MD V20Lung=1.67 (95%CI: −0.93, 4.28); MD DMediaHeart = 0.296 (95%CI: −1.25, 1.84).
Conclusions. The mean differences of the dosimetry parameters analyzed were not signiﬁcant with a conﬁdence interval of 95%.
http://dx.doi.org/10.1016/j.rpor.2013.03.088
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Introduction and objective. The aim of this work is to assess the accuracy of the dose calculation performed with a commercial
TPS for breast IMRT radiotherapy in presence of metallic expanders. A Monte Carlo method is used as gold standard for this
evaluation.
Materials and methods. Three breast patients with metallic expanders (model McGhan Style 150) were enrolled in this study. A
dynamic IMRT plan consisting of two tangencial ﬁelds was planned for each case using Eclipse TPS (v 10.0). The AAA algo-
rithm was used for 6MV beams. On the other hand, EGSnrc Monte Carlo algorithm was used to obtain the dose distribution for
each plan generated previously by the Eclipse TPS. MC simulations were performed using the BEAMnrc code for the treatment-
head simulation and the DOSXYZnrc code for the patient dose calculation. Dose volume histogram (DVH) for PTV was the
metric used to evaluate the accuracy of the AAA algorithm to calculate clinical dose distributions in the presence of a tissue
expander.
Results. Small dose differences (<2%) for PTV DVH were found between AAA and MC algorithms. Eclipse AAA algorithm overes-
timates the mean target dose about 2%.
Conclusions. Eclipse TPS (AAA algorithm) is able to compute reliable dose distribution when an expander is placed in the breast.
The clinical impact of the expander on the target dosage seems to be negligible.
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Objective. To present the case of a patient with brain metastases from breast cancer treated with Lapatinib and radiotherapy, who
developed an unexpected neurological disorder, and literature review.
Materials and methods. A 68-year old woman treated with neoadjuvant chemotherapy, mastectomy and adjuvant radiotherapy
for inﬁltrating lobular carcinoma pT2N2M0. After a two years of disease free interval, she developed bitemporal homonymous
hemianopsia, andwasdiagnosed byMRI ofmultiplemetastases in the brain, one localized in sellar regionwith compression of the
optic chiasm, two in the brain stemand three in both cerebellar hemispheres. The patient receivedwith 3Dholocraneal EBRTwith
a total dose of 35Gy 2.5Gy/day. After ﬁnishing treatment she showed improvement of visual symptoms. Subsequently, the patient
began treatment with Lapatinib (1250mg/day), requiring hospitalization in two occasions due to diarrhea and vomiting. Two
months later a brain MRI was performed, showing an 80% reduction in tumor volume of the sellar lesion, as well as others lesions.
Three months later of undergoing therapy with Lapatinib, she showed extrapyramidal clinical cognitive deﬁcits associated with
conduct disorder, and was diagnosed with atypical Parkinsonism after ruling out paraneoplastic origin.
Discussion and conclusion. The patient showed a signiﬁcant improvement in visual symptoms and a reduction in tumor volume
greater than 50% after treatment with Lapatinib and Radiotherapy; however she developed an extrapyramidal syndrome (ES)
later. At present, there is no data in the literature describing an ES neither after holocraneal radiotherapy nor as a side effect
of Lapatinib. The combination of both treatments in this patient during the same period of time made it possible to set down
ES as a result of interaction between both therapies, taking into account Lapatinib’s ability to cross the blood–brain barrier. The
neurological disorder progressed rapidly, resulting in the death of the patient, without evidence of tumor progression.
http://dx.doi.org/10.1016/j.rpor.2013.03.090
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Objectives. The purpose of this study was to analyse different approaches to correctly assess PTV doses in breast forward IMRT
(FIMRT).
Materials and methods. We selected a group of 40 patients undergoing radiotherapy after breast conserving surgery. Target volumes
were outlined: breast CTV and, by expansion, a PTV that extends outside the body surface. Two sub-volumes of PTV were further
established: a PTV-SV1, corresponding to the PTV 3 mm inside the body, and a PTV-SV2, corresponding to the rest of the PTV
(mostly air). For each patient 3 dosimetric planswere calculated according to the following situations: Plan 1. Using the delineated
PTV extended outside the body surface. Plan 2. Extending the body surface to include all PTV volume. Plan 3. Same as Plan 2 but
attributing a density to PTV-SV2 equal to the mean breast density. For each of these situations we evaluated the mean dose to
PTV and PTV-SV1 according to the ICRU 83 Report.
Results. We obtained different results for each of the studied situations. In all approaches the Dmean to PTV-SV1 was similar to
the prescription dose of 50Gy. However, only when a density was attributed to PTV-SV2 (Plan 3) the Dmean in PTV approached
the prescription dose.
Conclusions. According to ICRU 83 report, to correctly evaluate PTV volumes extended outside the body surface, several methods
have been proposed, for example by extending the beam intensity values from the breast periphery to the regions outside the
body. By attributing a density value to PTV-SV2 we were able to achieve this same goal even without the recurring to special IMRT
tools, not always available.
http://dx.doi.org/10.1016/j.rpor.2013.03.091
